Zeria Pharmaceutical Co., Ltd.
JPX: 4559.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sachiaki Ibe
- Employees
- 1,777
- Headquarters
- Tokyo, Japan
- IPO year
- 2001
- Market cap
- ¥94.6B
- Website
- https://www.zeria.co.jp
Loading 4559…
Loading profile data…Frequently asked questions about 4559
What does Zeria Pharmaceutical Co., Ltd. (4559.T) do?
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, fo...
Where does 4559.T trade?
Zeria Pharmaceutical Co., Ltd. (4559.T) trades on the Tokyo Stock Exchange.
What sector is 4559.T in?
Zeria Pharmaceutical Co., Ltd. (4559.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zeria Pharmaceutical Co., Ltd.?
Sachiaki Ibe is the chief executive officer of Zeria Pharmaceutical Co., Ltd. (4559.T).
Where is Zeria Pharmaceutical Co., Ltd. headquartered?
Zeria Pharmaceutical Co., Ltd. is headquartered in Japan.
Does 4559.T pay a dividend?
Yes — Zeria Pharmaceutical Co., Ltd. (4559.T) paid a trailing twelve-month dividend of JPY 48.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4559.T go public?
Zeria Pharmaceutical Co., Ltd. (4559.T) completed its initial public offering in 2001.